ten23 (private company)

See something wrong or missing? Let us know
Offices:Basel
Business model:B2B

ten23 is a Swiss specialized biologics-focused contract development and manufacturing organization with focus on formulation development, drug product development and manufacturing, as well as testing services for sterile pharmaceutical products.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to ten23

Name Criteria
Spain Ability Pharma
50%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
France AbolerIS Pharma
50%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Denmark Acesion Pharma
50%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Denmark AFYX Therapeutics
50%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Sweden Athera
50%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Sweden AttgeNO
50%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Denmark Bainan Biotech
50%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
United Kingdom Beckley Psytech
50%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
Denmark Biograil
50%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
Germany Biomes
50%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
Top